Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AF-pacemaker Tx Study
NCT03401593Not yet recruiting
- Sponsor
- Yonsei University
- Start
- Oct 2019
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib), atrial flutter (AFL) and atrial tachycardia (AT) (2 arms), sponsored by Yonsei University. Primary endpoints: Recurrence rate of Atrial Fibrillation/Atrial Flutter/Atrial Tachycardia at 1 year and Recurrence rate of Atrial Fibrillation/Atrial Flutter/Atrial Tachycardia (Long Term) at 5 years. Planned start Oct 2019; status: not yet recruiting.
02
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)atrial tachycardia (AT)
Beyond the preview
Go deeper on NCT03401593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03401593.